Company Filing History:
Years Active: 2012
Title: Jörg Keldenieh: Innovator in Pharmaceutical Chemistry
Introduction
Jörg Keldenieh is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address serious health conditions.
Latest Patents
Keldenieh holds a patent for I-phenyl 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use. This invention relates to 4-cyanophenyl, 2-sulfanyl, and 1-phenyl pyrimidine derivatives. The processes for their preparation and the pharmaceutical compositions derived from these compounds are particularly noteworthy. These compounds are useful in the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, and the development of heart failure. He has 1 patent to his name.
Career Highlights
Keldenieh is currently associated with Bayer Pharma Aktiengesellschaft, a leading company in the pharmaceutical industry. His work focuses on innovative solutions that enhance patient care and treatment outcomes.
Collaborations
Throughout his career, Keldenieh has collaborated with esteemed colleagues, including Heike Gielen-Haertwig and Volkhart Min-Jian Li. These collaborations have further enriched his research and development efforts.
Conclusion
Jörg Keldenieh's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in healthcare. His work continues to pave the way for advancements in the treatment of critical health issues.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.